硬科技与医疗持续活跃，无问芯穹完成近5亿元新融资｜21投融资

Core Insights - The technology and manufacturing sectors remain the primary focus for capital investment, with a significant number of financing events reported in the past week [1] - Artificial intelligence, robotics, semiconductors, and advanced manufacturing are highlighted as key areas of interest, with substantial funding rounds indicating strong investor confidence [1][3] - The healthcare sector also saw notable financing activity, reinforcing the dual focus on technology and healthcare as the most promising investment directions [1] Technology and Manufacturing Sector - A total of 36 financing events occurred in the domestic primary market from November 24 to November 30, with 27 disclosing amounts totaling approximately 40.17 billion RMB [1][2] - The artificial intelligence sector completed four financing rounds, raising about 7.6 billion RMB, while the biomedicine sector secured three rounds totaling approximately 3.9 billion RMB [3][4] - Key companies such as Shanghai Wunwen Chip and Jike Technology received significant funding, emphasizing the ongoing attractiveness of hard technology sectors [1][3][43] Healthcare Sector - Jiangsu Zhenyi Medical completed a multi-billion RMB C round financing, while Kaishikadi secured nearly 300 million RMB in B round funding [20][22] - Other companies like Jingwei Vision and Weike Biology also completed financing rounds exceeding 100 million RMB, indicating strong market confidence in innovative medical devices and biopharmaceuticals [1][20][22] Regional Financing Activity - Financing activities were concentrated in Jiangsu, Shanghai, and Beijing, with each region completing nine, nine, and seven financing events respectively [4][5] Active Investment Institutions - Yifeng Capital and BV Baidu Ventures were notably active, each completing two financing rounds primarily in technology and healthcare sectors [5][6]